News

Teva Receives FDA Approval for First Generic Lexapro

03/14/2012

The US Food and Drug Administration (FDA) granted the first generic Lexapro (escitalopram tablets) approval to treat adults with depression and generalized anxiety disorder. The drug, manufactured by Teva Pharmaceutical Industries, will come in 5 mg, 10 mg, and 20 mg strengths. Teva will have generic exclusivity for 180 days. Lexapro, manufactured by Forest Laboratories, had $2.59 billion in retail sales in 2010, according to data from Medco Health Solutions. The drug patent protection expired today. The FDA's news release is available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm296006.htm?source=govdelivery Read Teva's news release at https://www.tevapharm.com/Media/News/Pages/2012/1672770.aspx -Tim Casey

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

Newsfeed

High Cholesterol Is Significantly Undertreated

12/07/2018

Less than 40% of individuals with familial hypercholesterolemia (FH) receive appropriate high-intensity statin therapy, according to new research.

Less than 40% of individuals...

12/07/2018

First Report Managed Care

News

Pharmacists Take Larger Role on Health Team

08/16/2010

First Report Managed Care

News Connection

Some Physicians Charge Up to 6 Times What Medicare Pays

02/15/2017

Physicians, on average, charge roughly 2.5 times the amount Medicare actually pays, with some specialists—anesthesiologists, emergency physicians, and radiologists among them—charging up to 6 times what Medicare pays for the same service.

Physicians, on average, charge...

02/15/2017

First Report Managed Care

News

Democrats at odds over Medicare cuts

12/06/2011

First Report Managed Care

News

Adjuvant Anti-VEGF Drugs Unhelpful in Locally Advanced Kidney Cancer

02/23/2015

Adjuvant treatment with either sorafenib or sunitinib is unhelpful in locally advanced resected kidney cancer and should not be pursued.

Adjuvant treatment with either...

02/23/2015

First Report Managed Care

Video Insights

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Learn about the impacts of the...

05/24/2024

First Report Managed Care

Videos

Navigating Payment Models in the CGT Landscape: Insights and Innovations

05/21/2024

Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson

An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.

Teva Receives FDA Approval for First Generic Lexapro

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products